Liraglutide Response Investigation in Maturity-onset Diabetes of the Young Patients with Enteroendocrine Dysfunction and Metabolism Issues

This study focuses on individuals with a specific type of diabetes called Maturity-onset Diabetes of the Young (MODY). The goal is to understand how these patients' bodies process hormones and nutrients before and after they start taking a medication called liraglutide. Researchers hope that liraglutide will not only help improve blood sugar levels and weight but also alleviate digestive symptoms that some MODY patients experience. This research could lead to better treatment plans and care for people with this type of diabetes. Participants in the study will first undergo tests to measure their hormone levels and metabolism. After starting the liraglutide treatment, which is usually given as an injection, these tests will be repeated to see how their bodies respond. The study will track changes in blood sugar control, weight, and gastrointestinal symptoms. If certain individuals show significant improvement, scientists will use their cells to study why their bodies respond well to the medication. This approach seeks to uncover the underlying reasons for digestive issues in MODY patients and improve future treatments.